Literature DB >> 4027529

The results of surgical treatment of cancer of the rectum by radical resection and extended abdomino-iliac lymphadenectomy.

R E Glass, J K Ritchie, H R Thompson, C V Mann.   

Abstract

At St Mark's Hospital survival after radical surgery for cancer of the rectum has not changed significantly over the past 30 years. The technique of extended abdomino-iliac lymphadenectomy was developed in an attempt to improve prognosis in patients considered to have particularly unfavourable tumours. Between 1960 and 1981 the technique was used in 75 patients with a single adenocarcinoma of the rectum. Two patients died postoperatively and 52 patients developed complications; a mortality and morbidity similar to those seen after conventional surgery at this hospital. Five-year survival rate showed no improvement over that achieved by conventional techniques; disappointingly this was also the case for patients with Dukes' C1 tumours. The results of this study suggest that an improvement in survival in patients with cancer of the rectum is unlikely to be achieved by any extension of conventional radical surgery.

Entities:  

Mesh:

Year:  1985        PMID: 4027529     DOI: 10.1002/bjs.1800720805

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  18 in total

1.  Regional mesenteric recurrence of colorectal cancer after anterior resection or left hemicolectomy: inadequate primary resection demonstrated by angiography of the remaining arterial supply.

Authors:  P Hohenberger; P Schlag; U Kretzschmar; C Herfarth
Journal:  Int J Colorectal Dis       Date:  1991-02       Impact factor: 2.571

2.  Microscopic spread of low rectal cancer in regions of the mesorectum: detailed pathological assessment with whole-mount sections.

Authors:  Zhao Wang; Zongguang Zhou; Cun Wang; Gaoping Zhao; Youdai Chen; Hongkai Gao; Xuelian Zheng; Rong Wang; Daiyun Chen
Journal:  Int J Colorectal Dis       Date:  2004-12-22       Impact factor: 2.571

Review 3.  Is total pelvic exenteration reasonable primary treatment for rectal carcinoma?

Authors:  L F Williams; C B Huddleston; J L Sawyers; J R Potts; K W Sharp; S W McDougal
Journal:  Ann Surg       Date:  1988-06       Impact factor: 12.969

4.  Surgical strategies in locoregional recurrences of gastrointestinal carcinoma.

Authors:  C Herfarth; P Schlag; P Hohenberger
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

Review 5.  Is There Any Reason to Still Consider Lateral Lymph Node Dissection in Rectal Cancer? Rationale and Technique.

Authors:  Miranda Kusters; Keisuke Uehara; Cornelis J H van de Velde; Yoshihiro Moriya
Journal:  Clin Colon Rectal Surg       Date:  2017-11-27

6.  Utility of Preoperative Imaging for Predicting Pelvic Lateral Lymph Node Metastasis in Lower Rectal Cancer.

Authors:  Koji Numata; Yusuke Katayama; Sho Sawazaki; Akio Higuchi; Soichiro Morinaga; Yasushi Rino; Munetaka Masuda; Manabu Shiozawa
Journal:  Indian J Surg Oncol       Date:  2019-06-03

Review 7.  Analysis of local recurrence rates after surgery alone for rectal cancer.

Authors:  J L McCall; M R Cox; D A Wattchow
Journal:  Int J Colorectal Dis       Date:  1995       Impact factor: 2.571

8.  Laparoscopic rectal surgery for middle and lower rectal cancer.

Authors:  Yosuke Fukunaga; Masayuki Higashino; Shinnya Tanimura; Masashi Takemura; Yushi Fujiwara
Journal:  Surg Endosc       Date:  2009-06-11       Impact factor: 4.584

9.  Assessment of the prognostic factors for a local recurrence of rectal cancer: the utility of preoperative MR imaging.

Authors:  Young Taik Oh; Myeong Jin Kim; Joon Seok Lim; Joo Hee Kim; Kang Young Lee; Nam Kyu Kim; Won Ho Kim; Ki Whang Kim
Journal:  Korean J Radiol       Date:  2005 Jan-Mar       Impact factor: 3.500

10.  Microscopic spread of low rectal cancer in regions of mesorectum: pathologic assessment with whole-mount sections.

Authors:  Zhao Wang; Zong-Guang Zhou; Cun Wang; Gao-Ping Zhao; You-Dai Chen; Hong-Kai Gao; Xue-Lian Zheng; Rong Wang; Dai-Yun Chen; Wei-Ping Liu
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.